MUSTANG BIO, INC. Cash, Period Increase (Decrease)
MUSTANG BIO, INC. (MBIO) reported Cash, Period Increase (Decrease) of $47.51 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2017-05-15
- MUSTANG BIO, INC. cash, period increase (decrease) for the quarter ending 2017-03-31 was $47.51M.
- MUSTANG BIO, INC. cash, period increase (decrease) for the quarter ending 2016-12-31 was $16.38M.
- MUSTANG BIO, INC. cash, period increase (decrease) for the quarter ending 2016-03-31 was $0.00.
- MUSTANG BIO, INC. cash, period increase (decrease) for fiscal 2016 was $27.50M.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 7 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 10 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2017-03-31 | $47.51M 10-Q · filed 2017-05-15 | $63.89M derived: sum of 2 quarters · filed 2017-05-15 | ||||
| 2016-12-31 | $16.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $27.50M 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | $11.12M 10-Q · filed 2016-11-14 | |||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |